What is LMB's health score?

Limbach Holdings, Inc. (LMB) has a TradeApes health score of 65 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is LMB's estimated fair value?

Based on our 5-year discounted cash flow model, Limbach Holdings, Inc.'s estimated fair value is $23.21 per share, representing a -68.9% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is LMB undervalued or overvalued?

Our model currently rates LMB as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

Create an account for unlimited access

Limbach Holdings, Inc. (LMB)

Industrials Overvalued low healthy

$74.7

Updated: 2026-07-15

TradeApes Score

Financial Strength

85 Strong

Operating Trend

55 Mixed

Relative Value

60 Healthy

Capital Allocation

45 Mixed

Risk Management

80 Strong

Est. Fair Value $23.21

DCF Upside -68.9%

Sector Rank #368 of 7248

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− High P/E — 25–45×, growth premium already priced in

Unlock Full Report →

Industry Related Stocks

American Airlines Group Inc. (AAL) Absci Corp (ABSI) Arcosa, Inc. (ACA) Acco Group Holdings Ltd (ACCL) ACCESS Newswire Inc. (ACCS) ACORN ENERGY, INC. (ACFN)

See all Industrials stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.